ReviewJournal of lipid research2019

Lysophosphatidic acid type 2 receptor agonists in targeted drug development offer broad therapeutic potential.

Gabor J Tigyi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.